
|Articles|February 27, 2014
- NSCLC (Issue 2)
- Volume 2
- Issue 1
Treating Older Patients With NSCLC
Author(s)Chandra P. Belani, MD
Chandra P. Belani, MD, Deputy Director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses treating older patients who have non-small cell lung cancer
Chandra P. Belani, MD, Deputy Director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses treating older patients who have non-small cell lung cancer.
Learn more aboutthe treatment of older patients with NSCLC > >
Articles in this issue
almost 12 years ago
Crizotinib Resistance in ALK-Positive Lung Canceralmost 12 years ago
Clinical Update: ALK-Positive NSCLCalmost 12 years ago
PD-L1 as a Biomarker for Immunotherapy Agents in Lung Canceralmost 12 years ago
Treatment of Elderly Patients With NSCLCalmost 12 years ago
Current Challenges in Molecular Testing in NSCLCalmost 12 years ago
Individualized Maintenance Therapy for NSCLCalmost 12 years ago
Frontline Treatment Considerations in Non-Small Cell Lung Cancer



































